期刊文献+

化痰散结方对MCF-7/ADM裸鼠移植瘤逆转耐药机理研究 被引量:7

Research on Chinese Herbal Compound of Reducing Phlegm and Resolving Masses on Reversal of Multidrug Resistance Mechanism of MCF-7/ADM Transplantation Tumor in Nude Mice
下载PDF
导出
摘要 目的探究化痰散结方对乳腺癌MCF-7/ADM移植瘤的逆转耐药机制。方法制备荷瘤小鼠模型;设立生理盐水空白对照组、阿霉素组、阿霉素+维拉帕米组、阿霉素+中药低中高剂量组,观察肿瘤组织内阿霉素蓄积情况,用流式细胞仪(FCM)检测各组移植瘤耐药细胞P糖蛋白(P-gp)表达情况。结果中药组及维拉帕米组均能减轻瘤重,提高抑瘤率,与生理盐水组及阿霉素组比较均有统计学意义(P<0.05),中药组及维拉帕米组均能够降低P-gp含量、提高细胞内阿霉素浓度,其中高剂量中药组对细胞内阿霉素、P-gp的影响较维拉帕米组差异有显著性(P<0.05)。结论化痰散结方能逆转阿霉素耐药,增减肿瘤组织中阿霉素含量,并呈剂量依赖性,同时降低P-gp的表达。 Objective To explore the Compound of Reducing Phlegm and Resolving Masses on MCF-7/ADM breast cancer reversal of drug resistance mechanism .Methods Preparation of tumor bearing mice model .Set up the normal control group ,driamycin group , doxorubicin+verapamil group ,driamycin+internal medicine low and high dose group were observed in tumor tissue accumulation of doxoru -bicin case,by flow cytometry(FCM) to detect the drugresistant tumor cells P-glycoprotein(P-gp) expression.Results The traditional Chinese medicine group and the verapamil group reduced the tumor weight ,improve the tumor inhibition rate ,compared with the normal saline group and doxorubicin group were statistically significant (P〈0.05),Chinese medicine group and the verapamil group were able to reduce the content of P-gp,increase the intracellular doxorubicin concentration ,the high dose group in reducing effect on doxorubicin ,P-gp cells the verapamil group with significant difference (P〈0.05).Conclusion The Compound of Reducing Phlegm and Resolving Masses can reverse the resistance to doxorubicin concentration of adriamycin ,increase or decrease in tumor tissues ,and there are dose dependent ,and reducing the expression of P-gp.
出处 《潍坊医学院学报》 2014年第3期211-213,共3页 Acta Academiae Medicinae Weifang
基金 国家自然科学基金项目(编号:81273987)
关键词 化痰散结方 乳腺肿瘤 MCF-7 ADM 耐药 裸鼠 Compound of Reducing Phlegm and Resolving Masses Breast eancer MCF-7/ADM Multidrug resistance Nudemice
  • 相关文献

参考文献8

二级参考文献86

共引文献126

同被引文献108

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部